Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Needle in the Haystack: A Rare Case of Spontaneous Tumor Lysis in Newly Diagnosed Chronic Lymphocytic Leukemia Unmasked by Acute Renal Failure. | Cureus | 2020 | 33274154 | PubTator, text mining | PubMed |
| New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1. | J Clin Med | 2020 | 33261023 | PubTator, text mining | PubMed |
| Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist. | J Clin Med | 2020 | 33261016 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity. | Microorganisms | 2020 | 33260824 | PubTator, text mining | PubMed |
| Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation. | Haematologica | 2020 | 33256389 | PubTator, text mining | PubMed |
| Pathogenetic Mechanisms Implicated in Sjögren's Syndrome Lymphomagenesis: A Review of the Literature. | J Clin Med | 2020 | 33255258 | PubTator, text mining | PubMed |
| Linking Immunoevasion and Metabolic Reprogramming in B-Cell-Derived Lymphomas. | Front Oncol | 2020 | 33251150 | PubTator, text mining | PubMed |
| Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism. | Nucleic Acids Res | 2020 | 33245769 | PubTator, text mining | PubMed |
| Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression. | J Clin Med | 2020 | 33213108 | PubTator, text mining | PubMed |
| ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies. | Front Oncol | 2020 | 33194762 | PubTator, text mining | PubMed |
| Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? | Front Oncol | 2020 | 33194757 | PubTator, text mining | PubMed |
| Evolution of Advanced Chronic Lymphoid Leukemia Unveiled by Single-Cell Transcriptomics: A Case Report. | Front Oncol | 2020 | 33194728 | PubTator, text mining | PubMed |
| Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next? | Front Immunol | 2020 | 33193450 | PubTator, text mining | PubMed |
| [Treatment strategies for chronic lymphocytic leukemia in the era of novel targeted therapies]. | Rinsho Ketsueki | 2020 | 33162526 | PubTator, text mining | PubMed |
| Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review. | Cells | 2020 | 33147729 | PubTator, text mining | PubMed |
| Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing? | Front Oncol | 2020 | 33134182 | PubTator, text mining | PubMed |
| High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). | Haematologica | 2020 | 33131259 | PubTator, text mining | PubMed |
| Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG). | Haematologica | 2020 | 33131249 | PubTator, text mining | PubMed |
| Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia. | Cancer Manag Res | 2020 | 33116854 | PubTator, text mining | PubMed |
| Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients. | Sci Rep | 2020 | 33116240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=54